Fullerton F R, Hoover K, Mikol Y B, Creasia D A, Poirier L A
National Center for Toxicological Research, Jefferson, AR 72079.
Carcinogenesis. 1990 Aug;11(8):1301-5. doi: 10.1093/carcin/11.8.1301.
The ability of the dietary methyl donors methionine and choline to inhibit the carcinogenic and tumor-promoting effects of phenobarbital (PB) in the livers of male weanling C3H mice was examined. The mice were fed a commercial rodent diet with or without 0.05% PB. Thirty animals from each set received the diet with either: (1) no dietary supplementation, (2) an additional 1.0% choline chloride, (3) 1.5% DL-methionine or (4) both 1.5% DL-methionine and 1.0% choline chloride. Additional groups of 30 animals with the same eight dietary and PB-treatment regimens described above were given a single initiating dose of 150 mg diethylnitrosamine (DENA)/kg body wt dissolved in saline, or the saline solution only, 1 week prior to the start of PB feeding. The 16 treatment groups were fed their respective diets for 12 months. Statistical trend analysis showed that increasing levels of supplemental methyl donors gave highly significant protection in PB-treated mice (P less than 0.01). The incidence of liver carcinomas in the four dietary groups not receiving PB or DENA varied from 0 to 7%. The PB-treated animals not receiving an initiating dose of DENA developed hepatocellular carcinomas (HCCs) at incidences of 79% in group 1 animals, 74% in group 2 animals, 60% in group 3 animals, and 31% in group 2 animals respectively. Thus, incidence of HCCs in group 4 was significantly lower than in groups 1, 2 or 3 (P less than 0.01). However, the total incidence of liver tumors (adenomas plus carcinomas) was about the same in all DENA or PB-treated groups. Thus, dietary supplementation with methyl donors increased the proportion of animals bearing liver adenomas as their most advanced hepatic lesion in PB-treated mice. In DENA-treated mice fed PB, dietary supplementation with methionine and choline protected against the formation of liver carcinomas (P less than 0.02); however, methionine and choline had no significant effect on liver tumor formation in mice fed the PB-free diets. Methionine and choline supplementation gave significant protection against HCC metastases in the lungs of the tumor-bearing mice in groups initiated with DENA followed by PB promotion. These results support the hypothesis that PB exerts it tumorigenic activity in mice at least in part through a physiological insufficiency of labile methyl groups.
研究了膳食甲基供体蛋氨酸和胆碱抑制苯巴比妥(PB)对雄性断乳C3H小鼠肝脏致癌和促肿瘤作用的能力。给小鼠喂食含或不含0.05%PB的市售啮齿动物饲料。每组30只动物接受以下饲料之一:(1)不添加膳食补充剂;(2)额外添加1.0%氯化胆碱;(3)1.5%DL-蛋氨酸;(4)1.5%DL-蛋氨酸和1.0%氯化胆碱。另外30只动物组成的几组,采用上述相同的八种饮食和PB处理方案,在开始喂食PB前1周,给予单次起始剂量150mg/kg体重溶解于盐水中的二乙基亚硝胺(DENA),或仅给予盐溶液。16个处理组分别喂食各自的饲料12个月。统计趋势分析表明,补充甲基供体水平的增加在PB处理的小鼠中提供了高度显著的保护作用(P<0.01)。未接受PB或DENA的四个饮食组中肝癌的发生率在0%至7%之间。未接受起始剂量DENA的PB处理动物发生肝细胞癌(HCC)的发生率分别为:第1组动物79%,第2组动物74%,第3组动物60%,第4组动物31%。因此,第4组HCC的发生率显著低于第1、2或3组(P<0.01)。然而,所有DENA或PB处理组中肝肿瘤(腺瘤加癌)的总发生率大致相同。因此,在PB处理的小鼠中,膳食补充甲基供体增加了以肝腺瘤为最晚期肝脏病变的动物比例。在喂食PB的DENA处理小鼠中,膳食补充蛋氨酸和胆碱可预防肝癌的形成(P<0.02);然而,蛋氨酸和胆碱对喂食无PB饲料的小鼠肝脏肿瘤形成没有显著影响。在以DENA启动并随后用PB促进的组中,补充蛋氨酸和胆碱对荷瘤小鼠肺中HCC转移具有显著的保护作用。这些结果支持以下假设:PB至少部分通过不稳定甲基基团的生理不足在小鼠中发挥其致癌活性。